BRPI0411691A - l-lisina de aztreonam e seus métodos de preparação - Google Patents

l-lisina de aztreonam e seus métodos de preparação

Info

Publication number
BRPI0411691A
BRPI0411691A BRPI0411691-7A BRPI0411691A BRPI0411691A BR PI0411691 A BRPI0411691 A BR PI0411691A BR PI0411691 A BRPI0411691 A BR PI0411691A BR PI0411691 A BRPI0411691 A BR PI0411691A
Authority
BR
Brazil
Prior art keywords
aztreonam
lysine
preparation methods
methods
lysine salt
Prior art date
Application number
BRPI0411691-7A
Other languages
English (en)
Inventor
Viktor Gyollai
Csaba Szabo
Claude Singer
Istvan Bodi
Original Assignee
Teva Gyogyszergyar Reszvenytar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Gyogyszergyar Reszvenytar filed Critical Teva Gyogyszergyar Reszvenytar
Publication of BRPI0411691A publication Critical patent/BRPI0411691A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"L-LISINA DE AZTREONAM E SEUS MéTODOS DE PREPARAçãO". A presente invenção está relacionada ao sal L-lisina de aztreonam e aos métodos para a preparação do sal L-lisina de aztreonam.
BRPI0411691-7A 2003-07-02 2004-07-01 l-lisina de aztreonam e seus métodos de preparação BRPI0411691A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48486103P 2003-07-02 2003-07-02
US55009804P 2004-03-04 2004-03-04
PCT/US2004/021237 WO2005005424A1 (en) 2003-07-02 2004-07-01 Aztreonam l-lysine and methods for the preparation thereof

Publications (1)

Publication Number Publication Date
BRPI0411691A true BRPI0411691A (pt) 2006-12-26

Family

ID=34068199

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411691-7A BRPI0411691A (pt) 2003-07-02 2004-07-01 l-lisina de aztreonam e seus métodos de preparação

Country Status (10)

Country Link
US (2) US7262293B2 (pt)
JP (1) JP4741487B2 (pt)
AU (1) AU2004256124B2 (pt)
BR (1) BRPI0411691A (pt)
CA (2) CA2531170C (pt)
DE (1) DE112004001191B4 (pt)
ES (1) ES2304078B2 (pt)
IL (1) IL172802A (pt)
NO (1) NO333985B1 (pt)
WO (1) WO2005005424A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138419B2 (en) * 2000-12-27 2006-11-21 Corus Pharma, Inc. Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate
DE122011100043I1 (de) 2000-12-27 2011-12-15 Gilead Sciences Inc Inhalierbares aztreonam zur behandlung und vorbeugung von bakteriellen lungeninfektionen.
US7214364B2 (en) * 2000-12-27 2007-05-08 Corus Pharma, Inc. Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
KR100687001B1 (ko) * 2002-08-05 2007-02-27 테바 기오기스제르갸르 자르트쾨렌 뮈쾨되 레스즈베니타르사사그 아즈트레오남의 제법
WO2004103999A1 (en) * 2003-05-15 2004-12-02 TEVA Gyógyszergyár Részvénytársaság AZTREONAM β POLYMORPH WITH VERY LOW RESIDUAL SOLVENT CONTENT
AU2004256124B2 (en) * 2003-07-02 2011-04-28 Corus Pharma, Inc. Aztreonam L-lysine and methods for the preparation thereof
AU2014271333B2 (en) * 2003-07-03 2016-10-27 Gilead Sciences, Inc. Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
ES2321336T3 (es) * 2005-05-09 2009-06-04 Sicor Inc. Procedimiento para la fabricacion de aztreonam.
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
CN110898040B (zh) * 2018-09-18 2022-05-17 北京盈科瑞创新药物研究有限公司 一种吸入用氨曲南溶液用冻干粉及其制备方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923998A (en) 1977-03-14 1990-05-08 Fujisawa Pharmaceutical Company, Ltd. Cephem and cepham compounds and processes for preparation thereof
US4775670A (en) 1980-09-29 1988-10-04 E. R. Squibb & Sons, Inc. 2-oxo-1-azetidinesulfonic acid salts
US4529698A (en) 1981-01-19 1985-07-16 E. R. Squibb & Sons, Inc. Process for preparing a 2-oxo-1-azetidinesulfonic acid salt
US4946838A (en) 1981-07-13 1990-08-07 E. R. Squibb & Sons, Inc. Crystalline anhydrous aztreonam
CA1181075A (en) 1981-07-13 1985-01-15 David M. Floyd CRYSTALLINE ANHYDROUS FORM OF [3-S-[3.alpha.(Z),4 .beta.]]-3-[[(2-AMINO-4-THIAZOLYL) [(1-CARBOXY-1-METHYLETHOXY)IMINO]ACETYL] AMINO]-4-METHYL-2-OXO-1-AZETIDINESULFONIC ACID
US4652651A (en) 1983-05-31 1987-03-24 Hoffmann-La Roche Inc. Process for the manufacture of 1-sulpho-2-oxoazetidine carboxylic acid intermediates via catalytic ester cleavage
US4826973A (en) 1984-07-20 1989-05-02 E. R. Squibb & Sons, Inc. Delta form of aztreonam and preparation thereof
US4675398A (en) 1985-08-16 1987-06-23 E. R. Squibb & Sons, Inc. Copper-mediated oximation reaction
CA1339136C (en) * 1987-07-01 1997-07-29 Sailesh Amilal Varia Amorphous form of aztreonam
JP2653856B2 (ja) * 1988-11-08 1997-09-17 科学技術振興事業団 アミノ酸過酸化物の測定方法及び測定装置
US5254681A (en) 1989-08-02 1993-10-19 Consiglio Nazionale Delle Ricerche Process for preparing monobactames and their intermediate product
US5194604A (en) 1990-06-29 1993-03-16 E. R. Squibb & Sons, Inc. Process and intermediates for beta-lactams having aminothiazole(iminooxyacetic acid)acetic acid sidechains
PL165700B1 (pl) 1991-10-15 1995-01-31 Pan Sposób wytwarzania kwasu 32/2-amtnotiazoiilo-4/-2/1 -t-butoksykarbonylo- 1 -metyloetoksylmino/octowego
DE19652284A1 (de) * 1996-12-16 1998-06-18 Hoechst Schering Agrevo Gmbh Neue Gene codierend für Aminosäure-Deacetylasen mit Spezifität für N-Acetyl-L-Phosphinothricin, ihre Isolierung und Verwendung
US6756229B1 (en) * 1999-04-27 2004-06-29 Takeda Chemical Industries, Ltd. Human cell line showing stable expression of cytochromes P450
JP4320922B2 (ja) * 1999-06-04 2009-08-26 住友化学株式会社 エステラーゼ遺伝子及びその利用
WO2001034128A2 (en) 1999-11-08 2001-05-17 Pharmacia & Upjohn Company Admixture for intravenous administration of linezolid and other antibacterial agents
AUPQ872300A0 (en) * 2000-07-11 2000-08-03 Praxis Pharmaceuticals Pty Ltd Compounds and methods
US7214364B2 (en) * 2000-12-27 2007-05-08 Corus Pharma, Inc. Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
US7138419B2 (en) * 2000-12-27 2006-11-21 Corus Pharma, Inc. Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate
DE122011100043I1 (de) * 2000-12-27 2011-12-15 Gilead Sciences Inc Inhalierbares aztreonam zur behandlung und vorbeugung von bakteriellen lungeninfektionen.
MXPA03011769A (es) * 2001-06-29 2004-04-02 Lundbeck & Co As H Derivados de heteroarilo novedosos, su preparacion y uso.
WO2003018578A1 (en) 2001-08-27 2003-03-06 Aurobindo Pharma Ltd. Method for producing beta form of crystalline anhydrous aztreonam
CA2460541A1 (en) * 2001-09-14 2003-04-03 Helle Birk Olsen Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer
ATE407678T1 (de) * 2001-10-17 2008-09-15 Boehringer Ingelheim Pharma Pyrimidinderivate, arzneimittel enthaltend diese verbindungen, deren verwendung und verfahren zu ihrer herstellung
WO2003035030A1 (en) * 2001-10-24 2003-05-01 Pari Gmbh Kit for the preparation of a pharmaceutical composition
US20050043336A1 (en) * 2001-11-03 2005-02-24 Hennequin Laurent Francois Andre Quinazoline derivatives as antitumor agents
NZ532463A (en) * 2001-11-13 2007-02-23 Dimensional Pharm Inc Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
KR100687001B1 (ko) 2002-08-05 2007-02-27 테바 기오기스제르갸르 자르트쾨렌 뮈쾨되 레스즈베니타르사사그 아즈트레오남의 제법
EP1413603A1 (en) 2002-10-25 2004-04-28 Titecs Japan Corporation Vibration-damping material composition
EP1417958A1 (en) * 2002-11-08 2004-05-12 Pari GmbH Wet granulation process
WO2004052333A1 (en) * 2002-12-11 2004-06-24 Pari Gmbh Pharmaceutical compositions for the pulmonary delivery of aztreonam
WO2004103999A1 (en) 2003-05-15 2004-12-02 TEVA Gyógyszergyár Részvénytársaság AZTREONAM β POLYMORPH WITH VERY LOW RESIDUAL SOLVENT CONTENT
AU2004256124B2 (en) * 2003-07-02 2011-04-28 Corus Pharma, Inc. Aztreonam L-lysine and methods for the preparation thereof

Also Published As

Publication number Publication date
WO2005005424B1 (en) 2005-04-14
DE112004001191T5 (de) 2009-04-23
US20070167424A1 (en) 2007-07-19
ES2304078A1 (es) 2008-09-01
ES2304078B2 (es) 2009-09-16
WO2005005424A1 (en) 2005-01-20
AU2004256124A1 (en) 2005-01-20
US20050032775A1 (en) 2005-02-10
CA2531170C (en) 2011-05-10
CA2733145A1 (en) 2005-01-20
JP4741487B2 (ja) 2011-08-03
NO333985B1 (no) 2013-11-04
AU2004256124B2 (en) 2011-04-28
CA2531170A1 (en) 2005-01-20
JP2007521306A (ja) 2007-08-02
US7262293B2 (en) 2007-08-28
DE112004001191B4 (de) 2017-11-09
IL172802A (en) 2011-10-31
NO20060535L (no) 2006-02-01
CA2733145C (en) 2012-06-19
IL172802A0 (en) 2006-06-11
US7358093B2 (en) 2008-04-15

Similar Documents

Publication Publication Date Title
BRPI0410031A (pt) variantes fc otimizadas e métodos para sua geração
BRPI0417823A (pt) métodos para uso de bifidobactérias probióticas para animais de estimação
ITFI20050024A1 (it) Lipidi per l'alimentazione degli animali
IL181529A0 (en) Diagnostic compounds
IL182127A0 (en) Microcapsules and emulsions containing low bloom gelatine and methods for the preparation thereof
AR051470A1 (es) Criatales estables de natamicina en forma de aguja
IL185031A0 (en) Method for the preparation of pregabalin and salts thereof
EP1938155A4 (en) BUSINESS PROCESS EXECUTE ENGINE
BRPI0411691A (pt) l-lisina de aztreonam e seus métodos de preparação
BRPI0502382A (pt) processo para a preparação de artigos moldados de poliuretano
EP1845787A4 (en) FORMULATIONS FOR THE INJECTION OF CATHECHOLBUTANESE, INCLUDING NDGA COMPOUNDS, IN ANIMALS
BRPI0602309A (pt) processos para toners
BR0112463A (pt) Composições biocidas e métodos e sistemas que empregam as mesmas
EA200900780A1 (ru) Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства
BRPI0406824A (pt) Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm
BRPI0620229A8 (pt) formulação
ITTO20060517A1 (it) "passante per alloggiamento"
EA200800324A1 (ru) Новый способ получения солей тиотропия
BR0110206A (pt) Inibidores de peptìdeo deformilase
BR0110858B1 (pt) métodos para fazer peças de roupa com componentes de fixação.
BRPI0414732A (pt) piridilacetilenos para uso como radiotraçadores e agentes de imageamento
BR0313230A (pt) Uso de carboxamidas para o tratamento de tinido
BR0107483A (pt) Processo para a preparação de um composto
BRPI0406802A (pt) Derivados de 9-cetoespinosinas
PT9787U (pt) "fecho de embutir para caixilharia"

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]